Copy
ECRIN newsletter - April 2021 issue
View this email in your browser
ECRIN launches 2021-2023 Strategic Plan

This strategy sets out ECRIN’s priorities over the next three years. It defines the six areas of focus for ECRIN and carves out a path to advance our mission and vision. For each of the goals set out in this plan, distinct actions have been identified that will be carried out over the next three years.

Through the strategic plan, ECRIN looks to answer, even anticipate the users’ needs, be leading-edge as well as recognised as the reference in the setup and management of multinational clinical trials in Europe.
UPCOMING EVENTS
Don't miss International Clinical Trials Day: 20 May 2021

The theme of this year's event is Platform Trials: Shift in Treatment, Testing and Collaboration. This new trial format raises many questions, changes our approach to conducting clinical trials and testing for appropriate treatments. Through this online conference, we hope to help you answer some of the questions that come to mind when considering this new methodology. 

REGISTRATION IS NOW OPEN on the ECRIN.org website
Join us as we celebrate the outcomes and tools from the PedCRIN project

As the PedCRIN project comes to a close we share the tools that have been developed through the project. 
REGISTER for a webinar and / or save the date for the final event. 
The first webinar, Tools for the management of paediatric trials - Handling biosamples and assessing causality of adverse events, is now available for all. 
NEW TOOL: COVID-19 MARKETPLACE
ECRIN launches COVID-19 Marketplace

ECRIN has launched the Covid-19 Marketplace. This new, online tool aims to search for similar trial protocols to collaborate with, and to share trial protocols in order to get in touch with clinical researchers interested in the same topic. The Covid-19 Marketplace is freely available for all scientific researchers working in clinical research, and in particular on Covid-19. The research questions submitted are approved for inclusion in the database by the ECRIN team, based on their capacity to answer the medical communities need to advance Covid-19 research, and then made searchable on the Marketplace platform.
 
DATA CENTRE CERTIFICATION
Data Centre Certification Renewal

The ECRIN Data Centre Certification is pleased to share that one of its previously certified data centres, AIBILI, Coimbra (Portugal), received approval by the ECRIN Independent Certification Board (ICB) for certification renewal. 
 
PROJECT UPDATES
PERMIT hosts workshop on sample size

No generic approach for sample size estimation can be made in personalised medicine when designing a stratification cohort.  The approach for sample size estimation needs to be chosen according to the specific study type and goals as well as the parameters that influence the sample size. This workshop was the first in a series organised by the PERMIT project which will be used to elaborate the robust and reproducible recommendations for Personalised Medicine. 
PERMIT is funded by the European Union’s Horizon 2020 Research and Innovation programme under Grant Agreement number 874825.
EOSC-Life publishes mid-term Achievements brochure & new deliverable on the sensitive data sharing toolbox
 
EOSC-life published a mid-term achievements brochure to highlight the work that has been accomplished over the first 2 years of the project.   
Among the achievements discussed, is the development of a sensitive data sharing toolbox. A new publication summarises the work carried out to date on the development of this toolbox and the necessary steps towards it implementation.
EOSC-Life is funded by the European Union’s Horizon 2020 Research and Innovation programme under Grant Agreement number 824087.
VACCELERATE project kick-off

The kick-off of the new Pan-European vaccine network was held on 5 March 2021.  The network serves as a single entry-point for all stakeholders in COVID-19 vaccine development for phase 2 & 3 trials in Europe. 

Stay informed, VACCELERATE is now on Twitter: @vaccelerate_eu
 
VACCELERATE is funded by the European Union’s Horizon 2020 Research and Innovation programme under Grant Agreement number 101037867.
ECRAID-Base project launch
 
The ECRAID-Base (European Clinical Research Alliance for Infectious Diseases) initial kick-off took place on 2 March 2021 as a virtual meeting. 

ECRAID-Base is funded by the European Union’s Horizon 2020 Research and Innovation programme under Grant Agreement number 965313.
EU-Africa PerMed project kick-off
 
The EU-Africa PerMed (Building links between Europe and Africa in Personalised Medicine) project kicked off with a full-day virtual meeting on March 4 2021. This four-year project aims to integrate African countries into ICPerMed activities.  
EU-Africa is funded by the European Union’s Horizon 2020 Research and Innovation programme under Grant Agreement number 964333.
SIMCor website online

The SIMCor project has a new website highlighting its mission, strategic objectives, clinical focus and implementations phases. Visit simcor-h2020.eu and get to know the project. 
 
SIMCor is funded by the European Union’s Horizon 2020 Research and Innovation programme under Grant Agreement number 101017578.
ERIC Forum Chair Elections

Francisco Colomer, Director of JIVE ERIC, was elected the new Chair of the ERIC Forum. 
 
ERIC-Forum has received funding from the European Union’s Horizon 2020 programme under grant agreement number 823798.
ECRIN JOB OPENING
Project Manager - Clinical Research
 
ECRIN is currently hiring a new staff member to work in Paris with the core team as a Project Manager- Clinical Research. 
COVID-19 TASKFORCE UPDATES
COVID-19 Literature reviews

Funding Calls

COVID-19 Trials registries

Other COVID-19 resources
ECRIN NATIONAL PARTNER NEWS

CZECRIN and its partners coordinate national COVID-19 clinical research 
 
CZECRIN and its partners coordinate several national multicentric COVID-19 clinical trials: REMED which looks to identify an effective daily dose of dexamethasone in adults with COVID-19 and moderate to acute respiratory distress syndrome and CoVigi, a phase IV study, which monitors vaccine efficacy and safety against COVID-19.
 
 
FCRIN - COVIREIVAC platform launches new trials

COVIREIVAC, the French vaccinal platform coordinated by Inserm and F-CRIN  is being used for the clinical trial evaluating the efficacy of two doses of Janssen’s vaccine candidate, which began in February as well as other ambitious projects.

SCReN's new organisation taking shape

SCReN has moved its coordination unit from the Instituto de Investigación Sanitaria del Hospital Clínico San Carlos team to the Instituto de Investigación del Hospital Universitario La Paz team, IdiPaz. The new reorganisation will align the experience and capacity of SCReN's activities and will develop 11 working groups on key subjects for the network.  

SCTO Symposium - Medical devices: Lost in Translation

Following a one-year delay and the transition period, the European Union’s new Medical Devices Regulation (MDR) will become fully applicable on 26 May 2021. For reasons of consistency, Switzerland’s revised and new legislation on medical devices will enter into force in stages as well. 

The SCTO's Symposium will be held on 8 June 2021 and address the new requirements for medical devices as well as focus on the Swiss context. Registration is now open for this online event that will be held in English. 
 
More News from ECRIN's scientific partners:
Follow ECRIN on Twitter
Follow ECRIN on LinkedIn
Visit the ECRIN website
DATA PROTECTION

By subscribing to our newsletter, you have provided us with your name and email address. This personal data will be used solely for the purpose of keeping you up-to-date with ECRIN activities. We will keep your data for as long as your newsletter subscription is active. (Note: you may choose to unsubscribe at any time by clicking on the 'unsubscribe' link located at the bottom of our newsletter.)

To send you the newsletter, we use a very popular provider called MailChimp. If you subscribe to our newsletter, you consent that we send your contact information to Mailchimp, which stores your contact information in their servers.

Please be aware that Mailchimp has developed its own policy with respect to the GDPR and its own contractual terms and conditions. Please read their policy and if you do not agree with their policy, you must unsubscribe immediately from our newsletter. Should you have any questions concerning the way in which ECRIN is processing your data, please refer them to the following address: legal@ecrin.org
Copyright © 2021 ECRIN, All rights reserved.

Our mailing address is:
ECRIN
5 rue Watt
Paris 75013
France

Add us to your address book


New reader? Subscribe to our newsletter
Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list

Email Marketing Powered by Mailchimp